|
|
|
|
| LEADER |
01778nam a2200361 u 4500 |
| 001 |
EB000944471 |
| 003 |
EBX01000000000000000738061 |
| 005 |
20210907000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309146283
|
| 020 |
|
|
|a 9780309146289
|
| 100 |
1 |
|
|a Colvin, Heather M.
|
| 245 |
0 |
0 |
|a Hepatitis and liver cancer
|h Elektronische Ressource
|b a national strategy for prevention and control of hepatitis B and C
|c Heather M. Colvin and Abigail E. Mitchell, editors ; Committee on the Prevention and Control of Viral Hepatitis Infections, Board on Population Health and Public Health Practice
|
| 260 |
|
|
|a Washington, DC
|b National Academies Press
|c 2010, c2010
|
| 300 |
|
|
|a xix, 232 p.
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a Surveillance -- Knowledge and awareness about chronic hepatitis B and hepatitis C -- Immunization -- Viral hepatitis services
|
| 653 |
|
|
|a Hepatitis B / prevention & control
|
| 653 |
|
|
|a Liver Neoplasms / prevention & control
|
| 653 |
|
|
|a Hepatitis C / prevention & control
|
| 653 |
|
|
|a Hepatitis B / complications
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Hepatitis C / complications
|
| 653 |
|
|
|a Viral Hepatitis Vaccines / therapeutic use
|
| 700 |
1 |
|
|a Mitchell, Abigail E.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Committee on the Prevention and Control of Viral Hepatitis Infections
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Board on Population Health and Public Health Practice
|
| 710 |
2 |
|
|a National Academies Press (U.S.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK220039
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|